1. Home
  2. JFU vs NEPH Comparison

JFU vs NEPH Comparison

Compare JFU & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 9F Inc.

JFU

9F Inc.

HOLD

Current Price

$7.37

Market Cap

58.2M

Sector

Finance

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$5.02

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFU
NEPH
Founded
2006
1997
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.2M
60.0M
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
JFU
NEPH
Price
$7.37
$5.02
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
11.7K
74.6K
Earning Date
12-09-2022
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
3110.57
N/A
EPS
3.04
0.14
Revenue
$44,573,690.00
$17,930,000.00
Revenue This Year
N/A
$33.32
Revenue Next Year
N/A
$12.27
P/E Ratio
$2.78
$36.15
Revenue Growth
8.19
32.36
52 Week Low
$1.01
$1.39
52 Week High
$9.48
$6.42

Technical Indicators

Market Signals
Indicator
JFU
NEPH
Relative Strength Index (RSI) 70.30 48.33
Support Level $4.57 $4.83
Resistance Level $4.94 $5.97
Average True Range (ATR) 0.70 0.63
MACD 0.34 -0.03
Stochastic Oscillator 60.04 28.93

Price Performance

Historical Comparison
JFU
NEPH

About JFU 9F Inc.

9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: